AI entity
Every one of those 1 sits in a single category, partnership. AI is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 8, the average consequence score sits above the same-window beat average of 6.3.
Last mentioned: Feb 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, partnership. AI is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 8, the average consequence score sits above the same-window beat average of 6.3. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window. We currently track 1 AI story that mention Precision Medicine, all published on February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 140 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Precision Medicine. Shared-story counts are live from our verified record — not editorial picks.
Merck and Mayo Clinic have launched a strategic R&D collaboration to integrate artificial intelligence into drug discovery and precision medicine. The partnership combines Mayo Clinic's vast clinical data with Merck's therapeutic expertise to identify novel drug targets and personalize patient care.
Precision Medicine is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
